Serving leading biopharmaceutical companies globally:

Novartis
Fish and Richardson
Cantor Fitzgerald
US Army
Chinese Patent Office
Citi
Queensland Health
Chubb
Federal Trade Commission
Moodys

Simple Flat-Rate Pricing
Quarterly or Annual Plans • Discounts for Multiple Users/Years • Upgrade Anytime

Request a Callback or Demo

Name: *
Email: *
Company: *
Telephone: *
Message:

Pick Your Plan

 Most Popular  Most Comprehensive
Feature Ultimate Plan Premium Plan Basic Plan
Patents
Detailed Patent Information
International Patent Data -
Supplementary Protection Certificates (SPCs) -
Non-Orange Book Patents -
Expired Patents (1986 - Present) -
Patent Applications
Abandoned Patents - -
Pending Patent Applications - -
Granted Patent Applications - -
Patent Maintenance - -
Clinical Trials
Target Diseases - -
Trial Locations - -
Trial Progress - -
Trial Sponsors - -
Regulatory
Detailed Regulatory Status
Paragraph IV Challenges
Tentative Approvals (first generic entrants)
Drug Master File Listings
Authorized Generics -
Drug Information
Comprehensive Drug Information
Drug Class
Suppliers -
Bulk API Vendors - -
Manufacturing - -
Additional Features
Email Alerts
Data Export
Dynamic Trend Graphs
Price / Year $7995 $3995 $2995
► GET STARTED
Inquire about site licenses
► GET STARTED
Inquire about site licenses
► GET STARTED
Inquire about site licenses

Frequently Asked Questions

DrugPatentWatch has patent coverage for the following countries and regional organizations:

African Intellectual Property Organization (OAPI) African Regional IP Organization (ARIPO) Algeria Argentina Australia Austria Belgium Benin (OAPI) Bosnia and Herzegovina Botswana (ARIPO) Brazil Bulgaria Burkina Faso (OAPI) Cameroon (OAPI) Canada Central African Republic (OAPI) Chad (OAPI) Chile China Colombia Comoros (OAPI) Congo-Brazzaville (OAPI) Costa Rica Croatia Cuba Cyprus Czech Republic Czechoslovakia Côte d'Ivoire (OAPI) Denmark Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea (OAPI) Estonia Eurasian Patent Organization European Patent Office Finland France Gabon (OAPI) Georgia, Republic of German Democratic Republic Germany Ghana (ARIPO) Greece Guatemala Guinea (OAPI) Guinea-Bissau (OAPI) Gulf Cooperation Council Honduras Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Japan Jordan Kenya (ARIPO) Latvia Lesotho (ARIPO) Liberia (ARIPO) Lithuania Luxembourg Malawi (ARIPO) Malaysia Mali (OAPI) Mauritania (OAPI) Mexico Moldova, Republic of Monaco Montenegro Morocco Mozambique (ARIPO) Namibia (ARIPO) Netherlands New Zealand Nicaragua Niger (OAPI) Norway Panama Peru Philippines Poland Portugal Romania Russian Federation Rwanda (ARIPO) San Marino Saudi Arabia Senegal (OAPI) Serbia Sierra Leone (ARIPO) Singapore Slovakia Slovenia Somalia (ARIPO) South Africa South Korea Spain Sudan (ARIPO) Swaziland (ARIPO) Sweden Switzerland São Tomé and Príncipe (ARIPO) Taiwan Tajikistan Tanzania (ARIPO) The Gambia (ARIPO) Togo (OAPI) Tunisia Turkey Uganda (ARIPO) Ukraine United Kingdom United States of America Uruguay Viet Nam Yugoslavia Zambia (ARIPO) Zimbabwe (ARIPO)

Adding an alert is as easy as clicking the 'Add Alert' button on a page of interest.

    Available alerts include:

  • Paragraph IV challenges
  • New drugs and added or expired patents per company
  • Added or expired patents per drug
  • Tentative approvals

Enterprise Plans are available for unlimited users within your organization. The other plans cannot be shared, but multiple accounts can be purchased for a substantial discount. For more information on enterprise plans, please contact us

Please use the contact form and tell us which subscription plan you would like an invoice for.

No problem. Please use the contact form and let us know how we can be of assistance.

Clients in 65 Countries

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

botpot